of the agonist DAMGO inhibited currents through both wild-type (WT) and mutant Ca V 2.1 channels, which is consistent with the known modulation of these channels by G protein-coupled receptors. Prepulse facilitation, which is a way to characterize the relief of direct voltagedependent G protein regulation, was reduced by both FHM-1 mutations. Moreover,2 the kinetic analysis of the onset and decay of facilitation showed that the W1684R and V1696I mutations affect the apparent dissociation and reassociation rates of the Gβγ dimer from the channel complex, suggesting that the G protein-Ca 2+ channel affinity may be altered by the mutations.
Introduction
Migraine is a disabling neurovascular disorder that affects ~20% of the general population [1] . The disease is characterized by recurrent attacks of severe headache and associated autonomic symptoms, such as nausea and vomiting as well as photo-and phonophobia. In about one-third of the patients, the headache is preceded by transient focal neurological symptoms (migraine aura). Although migraine etiology and genetic influences at the population level are unknown, recent genome-wide association studies have identified the first gene variants for migraine. These findings connect a disturbed neuronal glutamate signaling with the pathophysiology of the disease [2, 3] .
Until now, the molecular insights on migraine pathophysiology came from studies on familial hemiplegic migraine (FHM), a monogenic subtype of migraine with aura. FHM can be considered a model for common migraine, because attacks in FHM patients are very similar to those in the common types, except for a long-lasting hemiparesis during the aura phase [4, 5] , and also because the FHM patients may exhibit migraine attacks with or without aura. Likewise, in FHM patients the clinical phenotype can also include epilepsy and/or cerebellar abnormalities ranging from nystagmus to progressive mild ataxia [6, 7] . Three genes are known to be associated with FHM. Mutations in CACNA1A and SCN1A, encoding the ion-conducting subunits of the neuronal voltage-gated P/Q-type Ca 2+ (Ca V 2.11 1 ) and Na + (Na V 1.1) channels, are responsible for FHM types 1 and 3 (FHM-1; FHM-3), respectively, whereas mutations in ATP1A2, coding the α2 subunit of the Na + -K + ATPase, are responsible for FHM-2 [5, 7, [8] [9] [10] .
The functional consequences of 13 of the 21 FHM-1 mutations in the CACNA1A gene have been tested for their consequences on Ca 2+ channel function using electrophysiology in heterologous expression systems [8] [9] [10] [11] . These studies have shown that the mutations alter 42 2 different properties of the human Ca V 2.1 channel. For instance, an enhanced channel open probability and increased single channel Ca 2+ influx associated to a shift to lower voltages of channel activation has been reported in HEK-293 cells and in Ca V 2.1α 1 null neurons transfected with FHM-1 mutant Ca V 2.1 channels [12, 13] . Likewise, a decreased density of functional channels and a consequent decreased maximal whole-cell Ca 2+ current density has also been reported for many FHM-1 mutants [12] [13] [14] . Investigation of the functional consequences of FHM-1 gene mutations R192Q and S218L in transgenic knock-in mice [15] [16] , revealed increased whole cell current densities, which are in line with single channel measurements, as well as increased cortical glutamatergic neurotransmitter release [17] , indicating that FHM-1 mutations more likely exert channel gain-of-function [10] [11] .
Much less is known, however, regarding the effects of FHM-1 mutations on the modulation of Ca V 2.1 channels by G proteins. Although no FHM-1 mutation has been found in the channel region involved in G-protein binding, initial studies revealed a reduction of Gprotein-mediated channel inhibition by specific FHM-1 mutations [18] [19] [20] , an effect that may lead to altered Ca 2+ influx through mutant channels during neuromodulation. Here, we studied the functional consequences of two FHM-1 mutations (W1684R and V1696I) located in the fourth repeat domain of the Ca V 2.1α 1 subunit on G-protein-mediated inhibition. Our results show that both mutants might have compromised G-protein coupling.
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Materials and Methods
Cell culture, cDNA clones and transfection
Human embryonic kidney (HEK) 293 cells (ATCC, Manassas, VA) were maintained in Dulbecco's modified essential medium-high glucose supplemented with 10% horse serum, 1% Lglutamine, 110 mg/L sodium pyruvate and antibiotics, at 37°C in a 5% CO 2 -95% air humidified atmosphere. Gene transfer was performed using Lipofectamine Plus reagent (Invitrogen, Carlsbad, CA) as described previously [19] . Briefly, for a 35-mm Petri dish of HEK-293 cells, 2 µg of the plasmid cDNA encoding the WT or the mutant variants of the human Ca V 2.1 (P/Qtype) Ca 2+ channel Ca V 2.1α 1 pore-forming subunit splice isoform 1A-2 (GenBank accession number AF004883) [21] ; in combination with 2 µg cDNA of the rat brain Ca V β 3 (M88751) [22] ; and 2 µg cDNA coding the WT rat brain Ca V α 2 δ-1b cDNA (M86621) [23] were premixed with 6 µL of Lipofectamine in 100 µL serum-free medium according to the manufacturer's instructions.
The solution was then added to the dish and cells grown at 37°C for 24 h, when medium was changed.
FHM-1 mutations were introduced into the human full-length cDNA encoding the Ca V 2.1α 1 subunit of the neuronal Ca V 2.1 (P/Q-type) Ca 2+ channel as previously described [24] .
Mutant PCR products harboring either mutation W1684R or V1696I were subcloned into a mammalian expression vector, and sequences were verified by DNA sequencing. The cDNA coding for the human µ-opioid receptor (hMOR; AY521028) was obtained from the UMR cDNA Resource Center www.cdna.org and used as previously reported [19, 25] .
SDS-PAGE and Western blots
Total extracts from transfected HEK-293 cells as well as from mouse brain (used as control),
were prepared as described elsewhere [26, 27] . Briefly, cells were harvested, washed twice with 62 2 PBS and homogenized during 20 min in cold lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5 mM PMSF, 1% of Triton X-100 and 1X complete -Roche Applied Science).
Homogenized samples were clarified by a 12,000 x g centrifugation step for 2 min. The supernatant was stored at -70°C. Aliquots of 100 µg of protein were mixed with sample buffer (50 mM Tris-HCl, 1.7% SDS, 5% glycerol, 0.002% bromophenol blue) and boiled for 5 min.
Samples were subjected to 10% SDS-PAGE electrophoresis and proteins were transferred to a nitrocellulose membrane (Hybond-N; GE Healthcare, Buckinghamshire, UK). After blocking with non-fat milk (5%) in TBS-T (100 mM Tris-HCl, 0.15 M NaCl, 0.05% Tween 20), membranes were incubated overnight with the primary anti-hMOR antibody (Invitrogen; Cat. # 44-308G) 1:1000 in TBS-T with 5% non-fat milk, washed in TBS-T, incubated with horseradish peroxidase goat anti-rabbit secondary antibody and developed with the Immobilon Western Chemiluminescent HRP Substrate (Millipore) according to the manufacturers' instructions.
Electrophysiological recordings
Ionic currents from HEK-293 cells were recorded 48 h after transfection at room temperature (~22°C) using the whole-cell configuration of the patch-clamp technique [28] at a sampling rate of 5.7 kHz and filtered at 2 kHz (four-pole Bessel filter). Linear leak and parasitic capacitance components were subtracted on-line using a P/4 protocol. Membrane capacitance (C m ) was determined as previously described [29] and used to normalize currents.
Data analysis 72 2
Current-voltage (I-V) relationships were obtained by step depolarization between -50 mV and +70 mV in 10 mV increments, from a holding potential (V h ) of -80 mV.2 To assess steady-state inactivation properties, a 2-s conditioning pulse to various potentials preceded a test depolarization to +10 mV.2 Inactivation curves were fitted with a Boltzmann function
, where the current amplitude (I Ba ) has decreased to a half-amplitude at V 1/2 with an e-fold change over k mV. Current remaining was measured from an average of 3 individual sweeps per recording using the equation: I rem =100*(I end /I peak ),2where I rem is the current remaining at the end of a 140-ms test pulse, I end is the value at the end of the test pulse, and I peak is the maximum current measured during the test pulse.2 Time constant (τ) of inactivation was obtained from single exponential fits of I Ba decaying phase using 140-ms test pulse to +10 mV.
The voltage-dependence of I Ba inhibition by the G-protein Gβγ dimer was examined by applying a family of 25-ms pulses to various voltages (between -50 mV and +70 mV in 10 mV steps) 500 ms after (P1) and 5 ms before (P2) a 50-ms conditioning prepulse to +100 mV, from a V h of -80 mV. Facilitation at different voltages was then determined as the ratio I Ba (P2/P1).
Facilitation decay and development (Gβγ reassociation and dissociation to the Ca V 2.1 channel, respectively) was studied as previously reported [18, 20] applying a three-pulse voltage protocol (Fig. 3A) . Facilitation decay was estimated applying two 25-ms test pulses (P1 and P2) to +10 mV separated by a conditioning prepulse to +100 mV (PP), and varying the time between PP and P2 (from 5 to 65 ms). Facilitation development was studied using a similar three-pulse voltage protocol varying the duration of the conditioning prepulse (from 5 to 25 ms). Plots of I Ba (P2/P1) as a function of time were fitted to single exponentials in order to obtain the corresponding time constants (τ).
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The time constant of dissociation and re-association (τ off and τ on ) were estimated by fitting the data to monoexponential equations of the form: P2/P1=1+I max [1-exp(-2t/τ off )] or P2/P1=1+I max [exp(-2t/τ on )], respectively, where P1 and P2 are the maximum currents before and after the strong depolarizing prepulse, 1+I max is the maximum ratio of facilitation and ∆t is the interpulse duration or prepulse duration, respectively.
Structural modeling of the segments S4 and S5 of domain IV in the Ca V 2.1α 1 subunit
Homology models of transmembrane2 segments IVS4 and IVS5 as well as the S4-S5 linker domain (residues 1653-1710) in the Ca V 2.1α 1 subunit were generated using the Robetta server (http://robetta.bakerlab.org). The structure of the Shaker potassium K V 1.2 channel model [30] was used as a template. Five models were generated and validated using the Stuctural Analysis and Verification Server (http://nihserver.mbi.ucla.edu/SAVES/Info.php) and the model with the best quality parameters was chosen for analysis. Computational methods for assigning partial charges and determining electrostatic potentials were applied using the Swiss-PdbViewer software (http://www.expasy.org/spdbv/). Electrostatic potentials and free energies were obtained by using a method based on the full nonlinear solution of the Poisson-Boltzmann equation [31] .
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Results
The neuronal Ca V 2.1 Ca 2+ (P/Q-type) channel contains a pore-forming Ca V 2.1α 1 (formerly α 1A ) subunit and several regulatory subunits including Ca V α 2 δ and Ca V β. The Ca V 2. We first characterized the impact of W1684R and V1696I FHM-1 mutations on current density and to this end, we transiently expressed Ca V 2.1α 1 channels in HEK-293 cells along with Ca V β 3 and Ca V α 2 δ-1 auxiliary subunits, and whole-cell Ba 2+ currents (I Ba ) were recorded two days after transfection. The presence of the mutations was verified by DNA sequencing (Suppl. were decreased in comparison with current density recorded in WT Ca V 2.1 channels (Fig. 1B) .
The potential for half-maximal activation was shifted ~5 mV to hyperpolarized potentials for the W1684R mutant channels, without changing the steepness of the I-V curve or the apparent reversal potential ( Fig. 2A; open circles) . Likewise, the half-maximal voltage for steady-state inactivation induced by conditioning prepulses ranging -110 to +50 mV was right-shifted ~5 mV in both W1684R and V1696I channels (Fig. 1C) . Such an effect was accompanied by a significant slowdown in I Ba decay during a 140-ms test pulses evoked from a V h of -80 mV to AB2 2 +10 mV. To quantify this effect, inactivation time constants (4 inact ) were obtained by fitting a single-exponential function to the decaying phases of Ca V 2.1 currents. W1684R and V1696I mutations increased τ inact 12-fold, and in consequence the current remaining at the end of the depolarizing pulse was also significantly increased (Fig. 1D) .
Given that leftward shifts in voltage-dependence of activation and slowed inactivation rate have been reported to facilitate recovery from direct G protein regulation [19] , we therefore investigated the effects of the W1684R and V1696I FHM-1 mutations on voltage-dependent Gβγ-mediated inhibition of recombinant Ca V 2.1 channels. To this end, recordings were then performed and current amplitude was examined after co-expressing the µ-opioid receptor (hMOR) using [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO), a synthetic opioid peptide with high specificity for hMOR. It is well known that hMORs couple to pertussis toxin (PTX)-sensitive G i /G o G-proteins to inhibit Ca 2+ channels [32] . Functional studies showed that exposure to 10 µM of DAMGO produced a rapid (within AA2 2 about 50% (Fig. 2B) . The inhibition was also present at the peak I Ba (0 to +10 mV) in both WT and FHM-1 mutant channel expressing cells (Figs. 2C and 2D); though DAMGO reduced I Ba only ~20% in cells expressing W1684R or V1696I mutant channels.2As current amplitudes were measured at their peak, these differences may reflect facilitated recovery from G protein inhibition occurring during membrane depolarization, therefore occurring between the start of the depolarization and the time to peak of the current [19] .
One key feature of G protein modulation of Ca V channels is its transient relief by a strong depolarizing prepulse. This phenomenon called facilitation is attributed to the dissociation of Gβγ dimers as channels undergo conformational changes in response to depolarization [18] [19] [20] . We took advantage of it to explore whether FHM-1 mutations alter the recovery from G protein mediated channel inhibition. Fig. 3B shows current traces through WT or mutant channels recorded during inhibition by DAMGO and elicited by 25-ms test pulses to the indicated potentials before (P1) and after (P2) the prepulse (PP) to +100 mV (Fig. 3A) . Co-expression of Ca V 2.1α 1 WT or the FHM-1 mutations together with Ca V β 3 and Ca V α 2 δ-1 subunits in HEK-293 cells resulted in current facilitation (larger P2 than P1 currents following the PP), reflecting the voltage-dependent relief of Gβγ-mediated channel inhibition.
Notably, in the presence of DAMGO the amplitudes of the currents through WT and FHM-1 mutant channels were facilitated at test potentials ranging from -10 to +20 mV (not shown). However, a clear difference in the magnitude of facilitation was observed. Both WT and mutant channels exhibited maximum facilitation at 0 mV, which was 1.58 ± 0.12 for WT, 1.36 ± 0.06 for W1684R and 1.39 ± 0.07 for V1696I channels. The biggest reduction in facilitation was observed at +10 mV. At this potential, facilitation was significantly reduced from 1.47 ± 0.05 in A12 2 the WT condition to 1.11 ± 0.03 and 1.36 ± 0.03 for W1684R and V1696I channels, respectively (Fig. 3C) .
The lower level of DAMGO-mediated inhibition observed for the W1684R and V1696I mutant channels (Fig. 2) associated to a smaller extent of facilitation (Fig. 3) , is consistent with changes in the Ca V 2.1α 1 subunit that result in alterations in the Gβγ-mediated inhibitory pathway.
It is worth mentioning that one of the major inhibitory pathways controlling Ca V channel activity at the synaptic level is mediated precisely by G-protein coupled receptor activation. In this context, the FHM-1 mutations may contribute to maintain Ca 2+ influx through Ca V 2.1 channels especially during high synaptic activity by promoting channel de-inhibition.
Combined, the two parameters mentioned above reflect either, i) a lower level of Gβγ-mediated inhibition on the mutant channels, or ii) a facilitated de-inhibition during the test pulse at higher voltages. Therefore, we sought to determine the mechanism underlying this difference.
To this end, we evaluated the time course for re-inhibition (at -80 mV) following facilitatory depolarization (facilitation decay) and for relief from inhibition (at +100 mV; facilitation onset), reflecting the association and dissociation rates of Gβγ dimers to/from the channel,2respectively.
The time constants for the onset and decay of facilitation can be measured by varying the parameters of the three-pulse voltage protocol. To monitor the onset of facilitation, the ratio of current amplitudes measured before and after the prepulse was plotted as a function of the conditioning pulse duration (Figs. 4A and 4B ). For each cell, facilitation was fitted by a single exponential to obtain a time constant (τ dissociation; Fig. 4C ). As can be seen in Fig. 4D , facilitation developed with an averaged time constant of 4.9 ± 0.5 ms for WT, 2.1 ± 0.5 ms and 3.8 ± 1.1 ms for W1684R and V1696I FHM-1 mutant channels, respectively. These results
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indicate that both FHM-1 mutations favor G protein dissociation from the channel during membrane depolarization.
The decay of facilitation was monitored by plotting the ratio of current amplitudes measured before and after the prepulse as a function of a variable interval between the conditioning prepulse and the second test pulse (Figs. 5A and 5B). For each cell, the decay of facilitation was fitted by a single exponential to obtain a time constant (τ re-association; Fig. 5C ).
Facilitation decayed with an averaged time constant of 27.8 ± 2.7 ms for WT, 15.2 ± 3.1 ms and 10.5 ± 1.0 ms for W1684R and V1696I channels, respectively (Fig. 5D ).
It is well established that the onset and decay of prepulse facilitation during Gβγ-induced inhibition can be represented by a simple two-state model (Fig. 6A) [18, [33] [34] [35] , where Ca V 2.1α 1 corresponds to the closed state of the channel, k on is the association kinetic constant and k off is the dissociation kinetic constant, both of them likely to have intrinsic voltage dependencies. During a facilitating depolarization to +100 mV, the Gβγ dimers should dissociate from the channels (Fig.   4) . If Gβγ subunits do not also rebind channels during the depolarization, then k off can be approximated by 1/τ off . On repolarization to -80 mV, Gβγ dimers should rebind to channels at a rate equal to k on [Gβγ] + k off . If at resting the inhibition of the channels by the Gβγ dimers is strong, as suggested by the results in Fig. 4 , then k off should be small, and k on [Gβγ] can be approximated by 1/τ on [36] .
Our results revealed that the time constants for Gβγ dissociation were different for WT and W1684R mutant channels (Fig. 4) in our kinetic analysis was ~204 for the WT Ca V 2.1α 1 subunit and ~261 and ~483 for the W1684R and V1696I mutant subunits, respectively, with a relative increase of ~1.3 and 2.4 fold (Fig. 6B) . On the other hand, assuming an intracellular concentration of 50 nM for the Gβγ dimer [35] , as well as that the interaction with the channels2occurs to a stoichiometric ratio of 1:1, the estimated on-rate [k on [Gβγ] (s -1 )] was 0.7, 1.3 and 1.9 x 10 9 (M -1 s -1 ) for the WT, the W1684R and the V1691I subunits, respectively. These alterations in kinetics may help explain the apparent reduced voltage-dependent inhibition by G proteins of the Ca V 2.1 mutant channels.
It is worth noting that there was a difference in the K d of Gβγ binding to the FHM-1 (V1696I < WT < W1684R). Though the reason for the difference in the affinity of the Gβγ dimer for the mutant channels is presently unknown, it is tempting to speculate that differences like this might be related to electrostatic potential changes occurring in the channels due to the presence of the mutations. It is well-known that the electrostatic potential plays an important role in many biological processes including folding, conformational stability, enzyme activity and proteinligand or protein-protein interactions [37] [38] [39] .
Given that hydrophobic interactions and electrostatic complementarity are important for high-affinity interactions, we decided to model the segments 4 and 5 of domain IV as well as the cytoplasmic loop connecting these two transmembrane segments in the Ca V 2.1α 1 subunit (where the studied mutations are located) and determine its electrostatic potential. Our analysis showed that the V1696I mutation did not result any change in the electrostatic potential in the region analyzed. However, the electrostatic potential was drastically affected by the W1684R mutation ( Fig. 7) due to the substitution of a nonpolar amino acid (tryptophan) for a polar one (arginine).
Interestingly, patients bearing the W1684R mutation, but not the V1696I mutation, have been shown to exhibit cerebellar ataxia as part of their phenotype [6] .
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Discussion
Ca V 2.1 (P/Q-type) channels are abundant in the mammalian brain where they mediate Ca 2+ influx across presynaptic and somatodendritic membranes, thereby triggering neurotransmitter release and other key neuronal responses [40] . Because of its high expression level in the brain, the pore-forming (α 1A ) subunit of the Ca V 2.1 channel was the first representative of its class to be isolated by cDNA cloning [41, 42] . Its importance also comes from the fact that mutations in the Ca V 2.1α 1 subunit can cause neurological diseases such as FHM-1, episodic ataxia type 2 (EA-2) and spinocerebellar ataxia type 6 (SCA-6) [43, 44] .
Inhibition of Ca V 2.1 channels by G protein coupled receptors is widespread and is important for controlling neurotransmitter release. The complexity of this protein signaling mechanism is vast and involves distinct pathways that may converge on these channels. Perhaps the most prominent is the so-called voltage-dependent inhibition mediated by direct binding of the G protein βγ dimer to the Ca V 2.1α 1 subunit of the channel [45, 48] .2Characteristic features of this modulation mechanism include a reduction in current amplitude, a slowdown in activation kinetics, and the development of prepulse facilitation during G protein regulation. These characteristics have been incorporated into models in which the Ca V 2.1 channels exhibit two functional gating states, "willing" and "reluctant" [48] . The reluctant channels are bound to Gβγ and display the voltage-dependent shifts in channel gating noted above.
Previous functional studies have investigated the response to G protein modulation of three different FHM-1 mutant channels [18] [19] [20] . Using recombinant Ca V 2.1 channels expressed in tsA-201 cells along with the dopamine D2 receptor, initial studies showed that the extent of G protein-mediated inhibition and the prepulse facilitation were reduced by the FHM-1 R192Q mutation. Since this mutation did not alter facilitation onset and decay or slow activation, it was A62 2 suggested that the Gβγ-Ca V channel affinity was not affected and that the consequences of the mutation were restricted to allosteric modifications that occurred after the Gβγ dimer bound to the channel [18] . More recently, we determined the functional consequences of, again, FHM-1 R192Q and mutation S218L mutations on G-protein regulation of Ca V 2.1 channels expressed in HEK-293 cells along with human µ-opioid receptors. Our results show that these mutations did not affect association of the Gβγ dimer onto the channel in the closed state but, in contrast to the results previously reported for R192Q, both mutations facilitated Gβγ dissociation from the activated channel, thereby decreasing the inhibitory G-protein pathway [19] .2 Similarly, more recently, it has been reported that also FHM-1 mutation Y1245C reduces G protein channel inhibition by favoring the dissociation of the Gβγ dimer from the channel [20] .
Our data provide the first detailed evidence that W1684R and V1696I mutations cause conformational changes in the Ca V 2.1α 1 subunit which result in alterations in the Gβγ-mediated inhibitory pathway. In particular, the results indicate that both FHM-1 mutations favor G protein dissociation from the channel during membrane depolarization. In a physiological context, this effect on G-protein regulation should contribute to render the neuronal network hyperexcitable, possibly as a consequence of reduced presynaptic inhibition, and help explain some aspects of the pathophysiology of FHM-1.
Likewise, studies in heterologous expression systems have shown that FHM-1 mutations may alter channel properties in a complex way, leading to both gain-and loss-of-function [10, 11, 49] . Our data suggest that the FHM-1 mutations W1684R and V1696I may influence Ca V 2.1 channels by affecting the dissociation of the Gβγ dimer. Although, a reduced channel density was observed in our data that could qualify as a possible mechanism (Fig. 1B) , there is general consensus that a reduction of current density is more likely due to the method of A72 2 heterologous expression given that no current reduction is observed when FHM-1 mutations are expressed in more physiological environment, i.e. in knock-in mouse mutants [15, 16] . Also the evidence that a reduction of mutant Ca V 2.1 expression results in EA-2, not FHM-1, would be in line with this.
Last, is not entirely clear how alterations associated with FHM-1 mutations play a role in the pathogenesis of the disease, but a favored hypothesis considers neuronal hyperexcitability in the cerebral cortex as the basis for susceptibility to disease [50] . Although the effects of the W1684R and V1696I mutations on overall neuronal excitability is difficult to predict, an increased postsynaptic excitability might result from this gain-of-function variants of presynaptic channels controlling release of excitatory neurotransmitters. Hence, in addition to altered response to direct G-protein regulation, it is possible that the mutations might interfere also with other molecular signaling important for neurotransmitter vesicle release. Though the two FHM-1 mutations reported here are located in conserved regions of the Cav2.1α 1 subunit (Fig. 1A) where no interaction sites with proteins of the exocytotic machinery has been reported, the possibility exists, that the altered responses of the mutant channels to G-protein regulation could result from inappropriate indirect interactions with such proteins. This is an interesting topic for future studies. 
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Figure Legends
